Comparison of the intracellular and extracellular activities of approved and novel antistaphylococcal antibiotics using a pharmacodynamic model exploring.

Slides:



Advertisements
Similar presentations
5/20/2015ISAP Is the cellular accumulation of antibiotics a predictive factor for intracellular efficacy ? Sandrine Lemaire Université catholique.
Advertisements

The Relationship between Daptomycin (DAP) Free drug AUC/MIC, Antibacterial effect (ABE) and Emergence of Resistance (EoR) in S.aureus. KE Bowker, AR Noel,
PK/PD of Antibiotics in relation to resistance Otto Cars MD Department of Medical Sciences Infectious diseases Uppsala University Sweden.
PK/PD - ICC - Manila, June 5th, The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul.
Hunting intracellular bacteria with antibiotics
Bacterial persistence
Setting-up a model of intracellular infection by Pseudomonas aeruginosa for the pharmacodynamic evaluation of antibiotic activity. J. Buyck1, O. Jolois2,
studies with Caco-2 cells and THP-1 macrophages
Activities of Daptomycin (DAP), Vancomycin (VAN) and Linezolid (LDZ) alone or in combination with Fusidic acid (FUS) in an in vitro dynamic model of.
A-052 Antibiotic (AB) activity against Pseudomonas aeruginosa (PA) with Normal or Mucoïd Phenotypes in an Artificial Sputum Medium (ASM) in vitro Biofilm.
Activity of tobramycin in combination with clarithromycin
Intracellular Infection of THP-1 Human Macrophages by Staphylococcus aureus and Role of Haemolysins Mailling adresse: Aurélie Olivier.
Intracellular antibiotics and Listeria monocytogenes
Françoise Van Bambeke & Paul M. Tulkens
In vitro pharmacodynamic models for the study of antibiotic activity against bacterial biofilms Françoise Van Bambeke, PharmD, PhD Pharmacologie cellulaire.
Mix with THP-1 macrophages Overnight bacterial suspension
Frédéric Peyrusson, Françoise Van Bambeke, Paul M. Tulkens
Wafi Siala1,2, Françoise Van Bambeke1 , Thomas Vanzieleghem2
Accumulation, Release and Subcellular Distribution of the Peptide Deformylase Inhibitor GSK in Murine Macrophages (J774) and Human Monocytes (THP-1)
Activity of 9 antibiotics against intracellular forms of S. pneumoniae
P1058 Intracellular activity of antibiotics against a stable small colony variant (SCV) isolated from a CF patient in a model Calu-3 human airway epithelial.
Volume 59, Issue 4, Pages (October 2009)
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul M. Tulkens Cellular and Molecular.
Revealing moxifloxacin activity against biofilms of S
Introduction & Purpose Results Conclusions
Oritavancin Kills S. aureus by Increasing Membrane Permeability without Causing Extensive Cell Lysis: Comparative Studies with Vancomycin, Daptomycin,
FUS, VAN and LZD injected twice (T0 and T12); DAP injected once (T0).
Intracellular Bacterial Infections: Why Are Antibiotics Poorly Efficient and Can We Do Something About it ? Paul M. Tulkens, MD, PhD * Cellular and Molecular.
Université catholique de Louvain
Introduction Results Aim Methods References Conclusion
Co-medications Improve Moxifloxacin (MXF) Activity in Models of Pneumococcal Naïve and Induced Biofilms (BF) N. M. Vandevelde1, M. Van Obbergh1, P.M. Tulkens1,
Background and objectives
Targeting Multidrug-resistant Staphylococci with an anti-rpoA Peptide Nucleic Acid Conjugated to the HIV-1 TAT Cell Penetrating Peptide  Mostafa FN Abushahba,
Activity and Pharmacodynamic (PD) Evaluation of Ceftazidime-Avibactam (CAZ-AVI) against Extracellular and Intracellular Forms of CAZ-susceptible and CAZ-resistant.
Inhibitors of type three secretion system [TTSS] protect against Pseudomonas aeruginosa cellular toxicity by inhibiting the transcription of TTSS Mailing.
Mapping French population [1]
Université catholique de Louvain, Brussels, Belgium
Emilien Drouot, Paul M. Tulkens, Françoise Van Bambeke
Julien Buyck, Paul M. Tulkens and Françoise Van Bambeke
Julien Buyck, Paul M. Tulkens and Françoise Van Bambeke
Extracellular activity Intracellular activity
Antibiotics in bone and joint infections
Abstract Results Methods Background Conclusions References
cellular accumulation (24h) Cstatic (LZD/RDZ ratio)
Apoptosis induced by aminoglycosides (AGs) in cultured cells : comparison between gentamicin (GEN) and amikacin (AMK) using incubated and electroporated.
Incubation (with antibiotic)
52 - Antimicrobials Radezolid (RX-1741), a Novel Oxazolidinone, Accumulates Extensively within Human Macrophages and PMNs and Shows Activity towards.
Of a Pig-related ST-398 Methicillin-Resistant S. aureus (A-MRSA)
EV0626 Cellular pharmacokinetics of gepotidacin (GSK )
Abstract Results Aim of the study Methods Background Conclusions
Difference log CFU from time 0
INTRODUCTION METHODS CONCLUSIONS REFERENCES
Pharmacodynamics of novel Mycobacteria tuberculosis DNA gyrase inhibitors EMMANUEL MOYO.
Electron microscopy: intracellular infection of THP-1 by S. aureus
Log extracellular concentration (mg/L)
Activity of Moxifloxacin against Staphylococcus aureus in Models of Persistent Infections (Intracellular Survival, Biofilms) Mailing address: P.M. Tulkens.
Correspondence: Bactericidal Activity of Fosfomycin against NDM-1 producing Enterobacteriaceae M. Albur, A. Noel, K. Bowker, A.
M.P. Mingeot-Leclercq, P.M. Tulkens, F. Van Bambeke
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
P1257 Pharmacodynamics of Amikacin Inhale studied in an in vitro pharmacokinetic model of infection KE Bowker, AR Noel, SG Tomaselli, MLG Attwood, AP.
Intracellular antibiotics
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Intracellular models of infection to evaluate antibiotic activity
Chemotherapy and PK/PD of intracellular infections
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Pharmacodynamic indices in targeting therapy of critical infections
Setting-up of a 24 h model to evaluate the activity of antibiotics against intracellular forms of S. aureus infection C. Seral, M. Barcia-Macay, F. Van.
“Pulmonary infections”
Are intracellular drug concentrations relevant for efficacy
Presentation transcript:

Comparison of the intracellular and extracellular activities of approved and novel antistaphylococcal antibiotics using a pharmacodynamic model exploring full drug concentration-responses. 3rd International Conference Pathophysiology of Staphylococci 15 - 17 September 2016, Tübingen Mailing address: F. Peyrusson av. Mounier 73 (B1.73.05) 1200 Brussels, Belgium frederic.peyrusson@uclouvain.be Frédéric Peyrusson, Paul M. Tulkens, Françoise Van Bambeke Cellular and Molecular Pharmacology, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium 1. Background and Model 2. Observations (equipotent concentrations [MIC normalized graphs) Infections caused by Staphylococcus aureus remain a therapeutic challenge, due, in part, to the ability of these organisms to survive in intracellular compartments of a variety of eukaryotic cells. In this context, our laboratory has undertaken to systematically measure and compare the activities of a large array of antibiotics (approved and in development) from different pharmacological classes against the intracellular and extracellular forms of S. aureus, using a pharmacodynamic model allowing for a quantitative assessment of their concentration- dependent effects in these environments. In brief, S. aureus isolates (susceptible to the antibiotics studied) are either (i) placed in broth (extracellular bacteria), or (ii) phagocytized by THP-1 monocytes (intracellular bacteria; non phagocytized bacteria are removed by washing and short term exposure of cells to gentamicin [100 x MIC]). Antibiotics are then added to the broth or to the monocytes culture medium for 24 h at concentrations ranging typically from 0.01 to 100 x the MIC to obtain full concentration-dependent responses and to calculate two pertinent pharmacodynamic parameters based on Hill's equation [sigmoidal function]. The figure shows a typical example of such a response for extracellular and intracellular forms of different S. aureus strains to an experimental antibiotic (peptide deformylase) and the parameters analyzed using different strains (compared at equipotent concentrations). 1. data with ATCC 25923 Emax Cs original inoculum limit of detection Emax (maximal relative efficacy): CFU change (in log10 units) at 24h from the post-phagocytosis inoculum as extrapolated for an infinitely large antibiotic concentration Cs (relative potency): extracellular concentration resulting in no apparent bacterial growth from CFU at 0h (CFU at 0h = post-phagocytosis inoculum). See also: In vitro Models for the Study of the Intracellular Activity of Antibiotics, In “Bacterial Persistence”, Molecular Biology Laboratory Protocols Series, J. Michiels and M. Fauvart, ed. 2016, p 147-157 Humana Press (Springer) (ebook) DOI: 10.1007/978-1-4939-2854-5 3. Pharmacodynamic parameters (from Hill's equation) antibiotic strain Emax ( log10 CFU) Cs (multiple of MIC) broth intracellular ceftaroline ATCC33591 -5.3 -0.56 0.5 0.8 multiple strains -5.1 -0.58 0.7 3.7 daptomycin -0.99 0.15 1.4 GSK1322322 a ATCC25923 -5.5 -0.48 1.9 3.8 gepotidacin b -1.10 1.3 1.1 moxifloxacin -4.3 -2.7 0.3 0.6 a peptide deformylase b topoisomerase type II inhibitor Data sources: Barcia-Macay et al. AAC 2006;50:841-51 | Melard et al. JAC 2013;68: 648-58 | Peyrusson et al. AAC 2015;59:5747-5760 | Peyrusson et al. 55th ICAAC & 25th ICC 2015; Poster no. A029 Maximal relative activity (Emax) Extracellular bacteria (broth) For all antibiotics shown here, a marked concentration-dependent bactericidal activity was noted with a reduction of the inoculum reaching or close to the lowest detection level (-5 log10 CFU) Intracellular bacteria For all antibiotics, activity is also concentration-dependent but the decrease of CFU is much lower (less negative Emax) than for activity in broth except for moxifloxacin. Relative Potency (Cs) The relative potencies of each antibiotic are roughly similar for extracellular (broth) and intracellular bacteria, and correspond essentially to the MIC in broth (0 on the abscissa [log scale]) 4. Discussion and Conclusions All antibiotics tested, except moxifloxacin, show a sharp decrease of their intracellular maximal relative efficacy (Emax) compared to broth, and are not bactericidal in cells (less than a 3 log10 CFU decrease compared to the post-phagocytosis inoculum) even though all are bactericidal in broth (3 log10 CFU or more); As Emax is the value extrapolated for an infinitely large extracellular concentration of antibiotics, this loss of efficacy cannot be due to a simple global lack of diffusion and accumulation of the antibiotics. Conversely, all antibiotics tested show similar relative potencies (Cs), in the range of their MIC in broth. This shows that intracellular bacteria are as susceptible as those in broth, indicating that the antibiotics tested are able to penetrate cells and reach their target (at least in part). We showed (not illustrated here) that intracellular S. aureus that remained in cells (i) are not Small Colony Variants (except in rare cases), and (ii) show an unaltered MIC when retested in broth. Intracellular bacteria, for a low but significant proportion of the original inoculum, are probably in a state of non-responsiveness to antibiotics. 2. data with multiple strains and ceftaroline (as an example) Strains with ceftaroline MICs ranging from 0.125 to 2 mg/L and with various susceptibility/resistance phenotypes to other antistaphylococcal antibiotics (0.125 mg/L: ATCC 25923 [MSSA]; 0.25 mg/L: 34843 [MSSA]; 0.5 mg/L: ATCC 33591 [MRSA], SA 555 [MRSA/VISA], SA 19834 (MRSA); 1 mg/L: NRS18 [MRSA/VISA], 35165 [MRSA]; 2 mg/L: 48046 [MRSA], CM05 [MRSA/LZDR], 062-13101 A [MRSA], 062-13091 A [MRSA]) Differences in Emax between broth and intracellular bacteria are observed together with Cs systematically close to MIC in broth (0 on the abscissa log scale) whatever the resistance phenotype of the strains examined. Data sources: Melard et al. JAC 2013;68: 648-58 This poster will be available after the meeting at http://www.facm.ucl.ac.be/posters.htm